Timing and outcomes of second‐line therapy in the era of daratumumab‐based frontline therapy in AL amyloidosis

Authors: Abdul‐Hamid Bazarbachi, Divaya Bhutani, Jai Radhakrishnan, Markus Mapara, Mathew S. Maurer, Suzanne Lentzsch, Rajshekhar Chakraborty

Published: 2024-08-03

DOI: HTTPS://DOI.ORG/https://doi.org/10.1002/ajh.27450

Keywords: No keywords found.

Abstract:
No abstract found.

Source: